Grantham, Mayo, Van Otterloo & Co (GMO)
UHS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Universal Health Services UHS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio UHS Stock Details UHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Sell
12,334
-62,406
-83% -$10.1M ﹤0.01% 451
2026
Q1 		$13.4M Buy
74,740
+33,861
+83% +$6.96M 0.03% 220
2025
Q4 		$8.91M Sell
40,879
-4,168
-9% -$921K 0.02% 248
2025
Q3 		$9.21M Buy
45,047
+25,748
+133% +$4.63M 0.03% 243
2025
Q2 		$3.5M Buy
19,299
+16,299
+543% +$2.94M 0.01% 330
2025
Q1 		$564K Buy
+3,000
New +$547K ﹤0.01% 538
2024
Q3 		– Sell
-1,621
Closed -$300K – 600
2024
Q2 		$300K Sell
1,621
-3,837
-70% -$679K ﹤0.01% 481
2024
Q1 		$996K Sell
5,458
-20,518
-79% -$3.39M ﹤0.01% 394
2023
Q4 		$3.96M Sell
25,976
-90,904
-78% -$12.2M 0.02% 297
2023
Q3 		$14.7M Sell
116,880
-60,886
-34% -$8.31M 0.07% 216
2023
Q2 		$28M Sell
177,766
-55,334
-24% -$7.72M 0.13% 139
2023
Q1 		$29.6M Sell
233,100
-46,300
-17% -$6.39M 0.15% 142
2022
Q4 		$39.4M Buy
279,400
+11,600
+4% +$1.37M 0.21% 96
2022
Q3 		$23.6M Buy
267,800
+20,900
+8% +$2.16M 0.14% 165
2022
Q2 		$24.9M Buy
246,900
+30,700
+14% +$3.84M 0.13% 169
2022
Q1 		$31.3M Buy
216,200
+5,200
+2% +$719K 0.15% 122
2021
Q4 		$27.4M Sell
211,000
-4,500
-2% -$578K 0.13% 130
2021
Q3 		$29.8M Buy
215,500
+18,600
+9% +$2.82M 0.15% 117
2021
Q2 		$28.8M Buy
196,900
+15,500
+9% +$2.34M 0.14% 120
2021
Q1 		$24.2M Buy
181,400
+36,400
+25% +$4.83M 0.13% 119
2020
Q4 		$19.9M Buy
+145,000
New +$18M 0.12% 109
2018
Q3 		– Sell
-3,600
Closed -$401K – 589
2018
Q2 		$401K Buy
+3,600
New +$422K ﹤0.01% 486
2016
Q3 		– Sell
-13,000
Closed -$1.74M – 586
2016
Q2 		$1.74M Sell
13,000
-7,700
-37% -$1.02M 0.01% 375
2016
Q1 		$2.58M Buy
20,700
+4,800
+30% +$540K 0.01% 354
2015
Q4 		$1.9M Buy
+15,900
New +$1.94M 0.01% 340
2014
Q1 		– Sell
-7,889
Closed -$641K – 637
2013
Q4 		$641K Sell
7,889
-340
-4% -$27.2K ﹤0.01% 508
2013
Q3 		$617K Buy
+8,229
New +$574K ﹤0.01% 519

Other funds holding UHS

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s UHS Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Universal Health Services (UHS) stake by 83% in Q2 2026, selling an estimated $10.1M and leaving 12,334 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in UHS in Q3 2013 and has held it in 27 quarters since. The position peaked at $39.4M in Q4 2022. 595 funds tracked by Wall St. Rank hold UHS as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 12,334 shares of Universal Health Services worth $1.83M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 62,406 Universal Health Services shares in Q2 2026, an estimated $10.1M.
  • Universal Health Services made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #451 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Universal Health Services in Q3 2013 and has held it in 27 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Universal Health Services position peaked at $39.4M in Q4 2022.
  • 595 funds tracked by Wall St. Rank held Universal Health Services as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.